Product Code: ETC9210228 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia HER2 Breast Cancer Test Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia HER2 Breast Cancer Test Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia HER2 Breast Cancer Test Market - Industry Life Cycle |
3.4 Serbia HER2 Breast Cancer Test Market - Porter's Five Forces |
3.5 Serbia HER2 Breast Cancer Test Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Serbia HER2 Breast Cancer Test Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Serbia HER2 Breast Cancer Test Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2-positive breast cancer cases in Serbia |
4.2.2 Growing awareness about the benefits of early HER2 testing for breast cancer patients |
4.2.3 Technological advancements leading to more accurate and efficient HER2 testing methods |
4.3 Market Restraints |
4.3.1 Limited access to HER2 testing facilities in certain regions of Serbia |
4.3.2 High costs associated with HER2 testing may deter some patients from undergoing the test |
4.3.3 Regulatory challenges and delays in the approval of new HER2 testing technologies |
5 Serbia HER2 Breast Cancer Test Market Trends |
6 Serbia HER2 Breast Cancer Test Market, By Types |
6.1 Serbia HER2 Breast Cancer Test Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia HER2 Breast Cancer Test Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Serbia HER2 Breast Cancer Test Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.1.4 Serbia HER2 Breast Cancer Test Market Revenues & Volume, By Fluorescence/chromogenic in situ hybridization (FISH/CISH), 2021- 2031F |
6.2 Serbia HER2 Breast Cancer Test Market, By End-user |
6.2.1 Overview and Analysis |
6.2.2 Serbia HER2 Breast Cancer Test Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Serbia HER2 Breast Cancer Test Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
7 Serbia HER2 Breast Cancer Test Market Import-Export Trade Statistics |
7.1 Serbia HER2 Breast Cancer Test Market Export to Major Countries |
7.2 Serbia HER2 Breast Cancer Test Market Imports from Major Countries |
8 Serbia HER2 Breast Cancer Test Market Key Performance Indicators |
8.1 Average turnaround time for HER2 test results |
8.2 Percentage of healthcare providers offering HER2 testing services |
8.3 Patient satisfaction with the HER2 testing process and results |
8.4 Adoption rate of new HER2 testing technologies in the market |
8.5 Number of clinical trials or studies conducted on HER2 testing efficacy and outcomes in Serbia |
9 Serbia HER2 Breast Cancer Test Market - Opportunity Assessment |
9.1 Serbia HER2 Breast Cancer Test Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Serbia HER2 Breast Cancer Test Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Serbia HER2 Breast Cancer Test Market - Competitive Landscape |
10.1 Serbia HER2 Breast Cancer Test Market Revenue Share, By Companies, 2024 |
10.2 Serbia HER2 Breast Cancer Test Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |